A clinical trial published in The Journal of Clinical Psychiatry found that a single dose of psilocybin paired with psychological support rapidly reduced chronic suicidal thoughts in adults with treatment-resistant depression, with 75% of participants showing significant improvement by week three and benefits persisting through twelve weeks. The study addressed a gap in research by including participants with active suicidal ideation, a population historically excluded from psychedelic trials due to safety concerns.
Topicle Beta
1 comment
A clinical trial published in The Journal of Clinical Psychiatry found that a single dose of psilocybin paired with psychological support rapidly reduced chronic suicidal thoughts in adults with treatment-resistant depression, with 75% of participants showing significant improvement by week three and benefits persisting through twelve weeks. The study addressed a gap in research by including participants with active suicidal ideation, a population historically excluded from psychedelic trials due to safety concerns.